ASCO Daily News

134 Episodo

1. What the FDA CAR T-Cell Therapy Investigation Means for Oncologists

   Publicado: 7/12/2023
2. Managing the Complexities of Oncology Practice in 2024

   Publicado: 7/12/2023
3. Solutions and Key Research to Advance High-Quality Cancer Care

   Publicado: 9/11/2023
4. How to Implement Universal Germline Testing for CRC

   Publicado: 2/11/2023
5. Changing the Gut Microbiome to Improve the Efficacy of Immunotherapy

   Publicado: 12/10/2023
6. Navigating the Complexities of Next-Generation Endocrine Therapy in HR+ Breast Cancer

   Publicado: 28/9/2023
7. ASCO Breakthrough: Scientific Innovations and Emerging Technologies in Cancer Care

   Publicado: 17/8/2023
8. How Oncologists Are Confronting the Cancer Drug Shortage

   Publicado: 10/8/2023
9. AI Will Allow Doctors to Reclaim Time With Patients

   Publicado: 3/8/2023
10. Managing the Side Effects of Endocrine Therapy for Breast Cancer

    Publicado: 27/7/2023
11. The Emergence of Triplet Therapies in ccRCC in the Frontline Setting

    Publicado: 13/7/2023
12. Novel Therapies in GI Oncology at ASCO23

    Publicado: 28/6/2023
13. THOR, CONTACT-03, and Other Advances in GU Cancers at ASCO23

    Publicado: 27/6/2023
14. Spotlight on Immunotherapy at ASCO23

    Publicado: 26/6/2023
15. Highlights in Hematologic Malignancies at ASCO23

    Publicado: 23/6/2023
16. ADAURA, KEYNOTE-671, and Other Key Advances in Lung Cancer at ASCO23

    Publicado: 22/6/2023
17. SONIA, NATALEE, and Other Advances in Breast Cancer at ASCO23

    Publicado: 21/6/2023
18. Addressing the Impact of Prior Authorization on Access to Cancer Treatment

    Publicado: 8/6/2023
19. ASCO23: RELATIVITY-047, CheckMate-038, and Other Advances in Immunotherapy

    Publicado: 25/5/2023
20. ASCO23: COMMANDS, CAPTIVATE, and Key Studies in Hematologic Malignancies

    Publicado: 25/5/2023